SearchDictionaryMobileLogin

John C Davis Selected Research

Wegener Granulomatosis (Wegener's Granulomatosis)

05/2008Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.
12/2007The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
11/2007Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
07/2007ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
05/2007Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.
05/2006Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
07/2005Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Articles by Research Topic

Disease

12Ankylosing Spondylitis
07/2008 - 05/2002
7Wegener Granulomatosis (Wegener's Granulomatosis)
05/2008 - 07/2005
1Pain (Aches)
07/2008
1Fatigue
07/2008
1Thrombophilia
12/2007

Drug/Important Bio-Agent (IBA)

8TNFR-Fc fusion protein (etanercept)FDA Link
08/2006 - 08/2003
3adalimumab (Humira)FDA Link
07/2008 - 07/2006
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2006 - 05/2002
2Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2007 - 07/2007
1GlucocorticoidsIBA
05/2008
1Anticardiolipin AntibodiesIBA
12/2007
1AntibodiesIBA
05/2007
1Biological Markers (Surrogate Marker)IBA
10/2005
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2003
1Thalidomide (Thalomid)FDA Link
08/2003
1pamidronate (APD)FDA LinkGeneric
08/2003